PD-L2 Expression in Breast Cancer Promotes Tumor Development and Progression
Background. This work focused on investigating the role of programmed death ligand 2 (PD-L2) in the progression of breast cancer by utilizing breast cancer specimens and cells. Materials and Methods. The serum levels of soluble PD-L2 (sPD-L2) in breast cancer patients and healthy individuals were an...
Saved in:
| Main Authors: | Yuling Sun, Jie Yang, Yachun Chen, Yundi Guo, Jian Xiong, Xuqin Guo, Yawen Zhang, Li Gu, Min Tong, Weipeng Wang, Jing Sun |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2024/3145695 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitors
by: Tao Wang, et al.
Published: (2025-03-01) -
PD-L1 on Circulating Tumor Cells Indicates Poor Prognosis in Breast Cancer
by: Xue-fei Wang, et al.
Published: (2022-11-01) -
Co‐Expression of MHC‐II and ANXA1: Mediators of PD‐1/PD‐L1 Therapy Resistance in Breast Cancer
by: Hao Wang, et al.
Published: (2025-08-01) -
EXPRESSION of MACROPHAGe-ASSOCIATED GENES IN BREAST TUMORS: RELATION TO TUMOR PROGRESSION
by: N. V. Litviakov, et al.
Published: (2017-12-01) -
KEAP1 promotes anti-tumor immunity by inhibiting PD-L1 expression in NSCLC
by: Jinghan Li, et al.
Published: (2024-02-01)